$2.47
-0.01-0.4%
Last update: Oct 30, 3:59 PM
Boundless Bio Inc (BOLD) Stock Price, Quote, News & History
BOLDNASDAQ
US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer staples up 1.4%, tech down 2.3%. S&P PMI rises.
You can purchase shares of Boundless Bio (NASDAQ:BOLD) through any online brokerage.
Other companies in Boundless Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Boundless Bio has a consensus price target of $8.00.
The stock price for Boundless Bio (NASDAQ: BOLD) is $2.47 last updated October 30, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Boundless Bio.
Boundless Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Boundless Bio.
Boundless Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene...
